Review of serotonergic signaling in autism spectrum disorder and other neurodevelopmental conditions

This publication is a narrative review focusing on the biological mechanisms of serotonergic signaling within the context of autism spectrum disorder and broader psychiatric disorders. The scope of the article encompasses various neurodevelopmental conditions, though specific study populations, sample sizes, and settings are not reported in the source material. The authors discuss the theoretical and observed associations between serotonin pathways and these conditions without providing pooled effect sizes or numerical data, as such details were not included in the input evidence.

The review synthesizes current understanding of how serotonergic signaling relates to the pathophysiology of these disorders. Key arguments center on the biological plausibility of these connections rather than clinical trial outcomes. Because the source is a review rather than a primary study, no specific intervention doses, comparators, or follow-up durations are described. The text avoids causal language, noting that the evidence is observational in nature.

Limitations acknowledged by the authors include the absence of quantitative data, specific adverse event rates, and definitive conclusions regarding clinical practice. The review does not report funding sources or conflicts of interest. Consequently, the practice relevance is described as uncertain, and clinicians are advised to interpret these qualitative findings with caution before applying them to patient care.